Haisco-usa Pharmaceuticals, Inc.
Clinical trials sponsored by Haisco-usa Pharmaceuticals, Inc., explained in plain language.
-
New anesthesia drug could replace propofol in surgeries
Symptom relief CompletedThis phase 3 trial tested whether a new drug called HSK3486 works as well as the standard drug propofol for putting adults under general anesthesia before elective surgery. About 400 participants received either HSK3486 or propofol to see if it safely and effectively induces anes…
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New sleep drug for surgery put to the test
Symptom relief CompletedThis study tested a new anesthetic called HSK3486 to see if it works as well as the standard drug propofol for putting adults to sleep before elective surgery. The trial involved 465 participants and compared success rates of inducing general anesthesia. The goal is to provide a …
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New sleep drug for surgery could rival propofol
Symptom relief CompletedThis study tested a new drug called HSK3486 to see if it works as well as propofol for putting adults to sleep before elective surgery. 255 people took part in a randomized, double-blind trial. The main goal was to see how many people had a successful start to anesthesia with HSK…
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New anesthetic HSK3486 put to the test: will it be safer than propofol?
Knowledge-focused CompletedThis study looked at whether a new anesthetic drug called HSK3486 has abuse potential similar to or lower than propofol, a common anesthetic. It involved 43 healthy adults who occasionally use depressant drugs recreationally. The goal was to find the right dose and compare how th…
Phase: PHASE1 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New anesthesia drug checked for heart risks in healthy volunteers
Knowledge-focused CompletedThis completed early-stage study looked at whether a single dose of HSK3486, an anesthesia drug, changes the heart's electrical activity in 48 healthy adults aged 18 to 45. The main goal was to measure any effects on heart repolarization (QTc interval) and check for side effects.…
Phase: PHASE1 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC